32 filings · most recent first
BDX 8-K Filings
Dr Michael Garrison To Retire From Bd
Bd Resumes Shipment Of Chloraprep And Purprep In The Us
Becton Dickinson Subsidiary Issues 600M In Notes
Becton Dickinson And Company Announces New Debt Issuance
Bd Announces Second Fiscal Quarter Financial Results
Becton Dickinson Amends Bylaws To Update Contested Election Notice Period
Retirement Of Executive Vice President Richard E Byrd
Bd Announces Spinoff Of Biosciences And Diagnostics Solutions Business
Becton Dickinson Announces Early Tender Results And Upsizing Of Tender Offers
Becton Dickinson And Company Announces Tender Offers For Outstanding Debt
Bd Completes Spinoff Of Biosciences And Diagnostic Solutions Business To Waters
Bd Announces Q1 2026 Results And Finalizes Biosciences And Diagnostic Solutions
Bd Announces Organizational Realignment Into Five Segments
Becton Dickinson Files For Preferred Stock Issuance In Spinoff
Becton Dickinson Adopts New Executive Severance Plan And Amends Equity
Bd Announces Temporary Trading Suspension In 401K Plan Due To Waters Transaction
Becton Dickinson Announces Appointment Of New Board Members
Bd Announces Additions To Board Of Directors
Bd Reports Fourth Fiscal Quarter 2025 Financial Results
Bd Announces Preliminary Revenue And Cfo Transition
Becton Dickinson And Company Announces Agreement To Combine Biosciences And
Bd To Combine Biosciences Diagnostic Solutions Business With Waters In 175
Bd Enters Third Amended Credit Agreement
Bd Announces Q3 2025 Financial Results And Raises Guidance
Proposed Settlement Of Stockholder Derivative Litigation
Becton Dickinson And Company Updates Corporate Governance Bylaws
Bd Reports Strong Q2 Results And Updates Fiscal 2025 Guidance
Becton Dickinson Appoints Gregory J Hayes To Board Of Directors
Bd Announces First Quarter Results And Plans To Separate Biosciences And
Bd Annual Meeting Voting Results Announced
Bd Appoints Pamela Spikner As New Chief Accounting Officer And Controller
Becton Dickinson Reports Strong Q4 2024 Financial Results